Federal Issue Brief

 S.1717, Prevention of Escapement of Genetically Altered Salmon in the United States Act

AVMA Position:

Nonsupport

Summary:

The Prevention of Escapement of Genetically Altered Salmon in the United States Act is purported to prevent the escapement of genetically altered salmon by prohibiting the sale of genetically altered salmon.  The legislation would make it unlawful for a person to (1) ship, transport, offer for sale, sell, or purchase genetically altered salmon or other marine fish, or a product containing genetically altered salmon or other marine fish, in interstate or foreign commerce; or (2) have custody, control, or possession of, with the intent to ship, transport, offer for sale, sell, or purchase genetically altered salmon or other marine fish, or a product containing genetically altered salmon or other marine fish, in interstate or foreign commerce.

Key Points of Opposition: 

  • The Prevention of Escapement of Genetically Altered Salmon in the United States Act would prevent the Food and Drug Administration (FDA) from completing their regulatory process for full evaluation of the first genetically engineered animal specifically intended for food.  Doing so could set a precedent for other legislation to supersede the scientific regulatory process, of which the AVMA is very supportive. 

  • This legislation is also inconsistent with the AVMA policy on the use of biotechnology in veterinary medicine and agriculture.

Current Status:

S. 1717 was introduced on 10/17/2011 by Senator Mark Begich (D-AK) and referred to the Committee on Commerce, Science, and Transportation.

AVMA Contact:

Dr. Ashley S. Morgan, 202-289-3210.